Back to Search Start Over

Drug industry

Authors :
Rho, George
Harris, Frederick L, III
Schlein, Milton
Gallen, David
Butler, Jeremy J.
Markey, Keith A.
Espaillat, Joseph
Feenan, Gerard
Jones, Stephen E.
Galeotafiore, Carrie
Clark, Charles
Reaves, Constance M.
Mitkowski, Robert, Jr.
Markovich, Steven
Romaine, Sigourney B.
Ferro, Mario
Source :
The Value Line Investment Survey (Part 3 - Ratings & Reports). Oct 29, 1999, Vol. 55 Issue 8, p1243, 40 p.
Publication Year :
1999

Abstract

Earnings and profits for the drug industry have been good for the second half of 1999 and this trend is expected to continue for the next ten years, as well, price hikes have a better environment, also. However, some drugs are losing patent protection in the coming years, and drug industry stock prices have fallen during 1999. These stocks are timely for investors due to good earnings and demographic trends in 1999 and later.

Subjects

Subjects :
ALZA Corp. -- Securities
Wyeth -- Securities
Amgen Inc. -- Securities
Barr Laboratories Inc. -- Securities
Biogen Inc. -- Securities
Block Drug Company Inc. -- Securities
Bristol-Myers Squibb Co. -- Securities
Chiron Corp. -- Securities
Covance Inc. -- Securities
Cygnus Inc. -- Securities
Immunetech Pharmaceuticals Inc. Dura Pharmaceuticals -- Securities
Elan Corp -- Securities
Forest Laboratories Inc. -- Securities
Genzyme Corp. -- Securities
Glaxo Wellcome PLC -- Securities
Human Genome Sciences Inc. -- Securities
Valeant Pharmaceuticals International -- Securities
IDEC Pharmaceuticals Corp. -- Securities
Immunex Corp. -- Securities
Inhale Therapeutic Systems Inc. -- Securities
IVAX Corp. -- Securities
Jones Pharma Inc. -- Securities
Eli Lilly and Co. -- Securities
MedImmune L.L.C. -- Securities
Merck & Company Inc. -- Securities
Monsanto Co. -- Securities
Mylan Inc. -- Securities
PAREXEL International Corp. -- Securities
Perrigo Co. -- Securities
Pfizer Inc. -- Securities
Pharmaceutical Product Development Inc. -- Securities
Pharmacia and Upjohn Inc. -- Securities
Quintiles Transnational Corp. -- Securities
Roberts Pharmaceutical Corp. -- Securities
Schering-Plough Corp. -- Securities
Sicor Inc. -- Securities
SmithKline Beecham Corp. -- Securities
Warner-Lambert Co. -- Securities
Watson Pharmaceuticals Inc. -- Securities
Pharmaceutical industry -- Securities
Business
Business, general

Details

ISSN :
00422401
Volume :
55
Issue :
8
Database :
Gale General OneFile
Journal :
The Value Line Investment Survey (Part 3 - Ratings & Reports)
Publication Type :
Periodical
Accession number :
edsgcl.57530094

Tools

Authors Abstract Subjects Details